Department of Cardiology, Tenri Hospital, Tenri, Japan.
Congenital Heart Disease Center, Tenri Hospital, Tenri, Japan.
Eur J Cardiothorac Surg. 2023 Feb 3;63(2). doi: 10.1093/ejcts/ezac528.
There are no data on long-term outcomes beyond 30 years after the Glenn procedure without the subsequent Fontan procedure in patients with single-ventricle physiology. Hence, this study aimed to clarify the very long-term outcomes of these patients.
This single-centre, retrospective cohort study investigated the clinical outcomes of patients with single-ventricle physiology who underwent the Glenn procedure between 1970 and 1999. Those who underwent the subsequent Fontan procedure were excluded. The primary outcome was all-cause death. The secondary outcome was a composite of all-cause death, arrhythmic events, neurological events or infective endocarditis. The prognostic factors associated with the long-term outcomes were also evaluated.
In total, 36 patients were enrolled (median age at Glenn procedure: 6.2 years, 56% male). During a median follow-up of 17.6 years (interquartile range: 6.1-33.4), 21 patients died and 29 experienced the composite outcome. The 20-, 30- and 40-year overall survival after the Glenn procedure was 51.2%, 44.4% and 40.3%, respectively. The 20-, 30- and 40-year event-free survival was 36.0%, 25.5% and 14.5%, respectively. Patients with dominant left ventricular morphology had better overall survival than those with dominant right ventricular morphology (hazard ratio: 0.24, 95% confidence interval: 0.08-0.76, P = 0.014). None of the patients had liver cirrhosis but 1 had protein-losing enteropathy.
The 40-year overall survival after the Glenn procedure without the subsequent Fontan procedure in patients with single-ventricle physiology was 40.3%. Dominant left ventricular morphology may be associated with better long-term overall survival than dominant right ventricular morphology.
对于单心室生理患者,在未行后续 Fontan 手术的情况下,Glenn 手术后 30 年以上的长期结果尚无数据。因此,本研究旨在阐明这些患者的非常长期结果。
这项单中心回顾性队列研究调查了 1970 年至 1999 年间接受 Glenn 手术的单心室生理患者的临床结果。排除了随后接受 Fontan 手术的患者。主要结局是全因死亡。次要结局是全因死亡、心律失常事件、神经事件或感染性心内膜炎的复合结局。还评估了与长期结果相关的预后因素。
共纳入 36 例患者(Glenn 手术时的中位年龄:6.2 岁,56%为男性)。在中位随访 17.6 年(四分位距:6.1-33.4)期间,21 例患者死亡,29 例患者发生复合结局。Glenn 手术后 20 年、30 年和 40 年的总体生存率分别为 51.2%、44.4%和 40.3%。20 年、30 年和 40 年无事件生存率分别为 36.0%、25.5%和 14.5%。左心室优势形态的患者总体生存率优于右心室优势形态的患者(风险比:0.24,95%置信区间:0.08-0.76,P=0.014)。无患者发生肝硬化,但有 1 例发生蛋白丢失性肠病。
在单心室生理患者中,不进行后续 Fontan 手术的 Glenn 手术后 40 年的总体生存率为 40.3%。左心室优势形态可能与右心室优势形态相比,具有更好的长期总体生存率。